In a previous study on the initiation phase of CRC, we reported that ApcMin/+ mice lacking the CB2 receptor (ApcMin/+CB2−/−) have more prominent adenomagenesis [8]. The gene discussed is CNR2; the disease is colorectal carcinoma.